Therapie der Mitralklappeninsuffizienz: Chirurgische und interventionelle Neuerungen
Standard
Therapie der Mitralklappeninsuffizienz: Chirurgische und interventionelle Neuerungen. / Conradi, L; Treede, H; Baldus, S; Seiffert, M; Blankenberg, S; Reichenspurner, H.
in: HERZ, Jahrgang 36, Nr. 8, 12.2011, S. 677-685.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Therapie der Mitralklappeninsuffizienz: Chirurgische und interventionelle Neuerungen
AU - Conradi, L
AU - Treede, H
AU - Baldus, S
AU - Seiffert, M
AU - Blankenberg, S
AU - Reichenspurner, H
PY - 2011/12
Y1 - 2011/12
N2 - Surgical mitral valve repair has constantly evolved to become the standard of care for severe mitral regurgitation (MR) with superior acute and long-term results compared to valve replacement. Minimally-invasive surgical techniques have been successful in reducing operative trauma while yielding equivalent or even superior results compared to the conventional sternotomy approach. However, due to elevated operative risk a growing proportion of patients are not referred for surgery, especially elderly patients with reduced ventricular function and functional MR who often present with relevant comorbidities. It is for these patients that transcatheter-based therapies may represent an attractive option. While most interventional techniques are still in experimental or early clinical stages of development, relevant clinical experience has been gained with the MitraClip® device. For successful implementation of a patient-centered mitral valve program, integration of surgical and interventional treatment modalities within a heart center is of paramount importance. This is best accomplished by an interdisciplinary dedicated heart team consisting of cardiologists and cardiac surgeons.
AB - Surgical mitral valve repair has constantly evolved to become the standard of care for severe mitral regurgitation (MR) with superior acute and long-term results compared to valve replacement. Minimally-invasive surgical techniques have been successful in reducing operative trauma while yielding equivalent or even superior results compared to the conventional sternotomy approach. However, due to elevated operative risk a growing proportion of patients are not referred for surgery, especially elderly patients with reduced ventricular function and functional MR who often present with relevant comorbidities. It is for these patients that transcatheter-based therapies may represent an attractive option. While most interventional techniques are still in experimental or early clinical stages of development, relevant clinical experience has been gained with the MitraClip® device. For successful implementation of a patient-centered mitral valve program, integration of surgical and interventional treatment modalities within a heart center is of paramount importance. This is best accomplished by an interdisciplinary dedicated heart team consisting of cardiologists and cardiac surgeons.
KW - Heart Valve Prolapse
KW - Heart Valve Prosthesis Implantation
KW - Humans
KW - Minimally Invasive Surgical Procedures
KW - Mitral Valve Insufficiency/surgery
KW - Treatment Outcome
U2 - 10.1007/s00059-011-3531-7
DO - 10.1007/s00059-011-3531-7
M3 - SCORING: Zeitschriftenaufsatz
C2 - 21994032
VL - 36
SP - 677
EP - 685
JO - HERZ
JF - HERZ
SN - 0340-9937
IS - 8
ER -
